New Drug Approvals
Home | Pages | Archives
Posts tagged: EU 2018
- Caplacizumab-yhdp, カプラシズマブ February 8, 2019 -
- Caplacizumab, カプラシズマブ Cablivi is the first therapeutic approved in Europe, for the treatment of a rare blood-clotting disorder October 29, 2018 -
- Sodium zirconium cyclosilicate, ナトリウムジルコニウムシクロケイ酸塩 September 10, 2018 -
- Inotersen sodium, イノテルセンナトリウム August 27, 2018 -
- Anagrelide アナグレリド , April 11, 2018 -
Mobile Site | Full Site
Get a free blog at WordPress.com Theme: WordPress Mobile Edition by Alex King.